PRISM BioLab Co.,LTD's latest marketcap:
As of 07/28/2025, PRISM BioLab Co.,LTD's market capitalization has reached $53.06 M. According to our data, PRISM BioLab Co.,LTD is the 29597th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 53.06 M |
| Revenue (ttm) | 0 |
| Net Income (ttm) | 0 |
| Shares Out | 35.95 M |
| EPS (ttm) | 0 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/14/2025 |
PRISM BioLab Co.,LTD's yearly market capitalization.
| Date | Market Cap(¥) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/28/2025 | ¥7.87 B | $53.06 M | -24.48% | 29597 |
| 12/30/2024 | ¥10.43 B | $66.32 M | 26018 |
Company Profile
About PRISM BioLab Co.,LTD
PRISM BioLab Co.,LTD is a biotechnology company specializing in the discovery and development of small molecule inhibitors targeting protein-protein interactions. Utilizing its proprietary PepMetics technology, the company focuses on creating treatments for cancer, autoimmune disorders, fibrosis, and other diseases.
Key Pipeline Developments
- E7386 - Targeting CBP/beta-catenin, currently in Phase II clinical trials for cancer treatment.
- PRI724 - Also targeting CBP/beta-catenin, in Phase II clinical trials for cirrhosis treatment.
Strategic Collaborations
The company has established key license agreements with:
- Eisai Co., Ltd.
- Ohara Pharmaceuticals Co.,Ltd.
These partnerships focus on the development of drugs for cancer and liver diseases.
Company Background
Founded in 2006, PRISM BioLab Co.,LTD is headquartered in Fujisawa, Japan.
Frequently Asked Questions
-
What is PRISM BioLab Co.,LTD's (TYO-206A) current market cap?As of 07/28/2025, PRISM BioLab Co.,LTD (including the parent company, if applicable) has an estimated market capitalization of $53.06 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does PRISM BioLab Co.,LTD (TYO-206A) rank globally by market cap?PRISM BioLab Co.,LTD global market capitalization ranking is approximately 29597 as of 07/28/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.